Caroline Gahm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Caroline Gahm has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Elliot
Karolinska University Hospital
2 shared publications Andreas Ekborn
2 shared publications- Lalle Hammarstedt-Nordenvall
Department of Clinical Sciences Intervention and Technology, Division of Ear Nose and Throat Diseases Karolinska Institute Stockholm Sweden
2 shared publications Malin Wendt
Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden
2 shared publications- Malin Wendt
Department of Clinical Sciences Intervention and Technology, Division of ENT Diseases Karolinska Institute Stockholm Sweden
2 shared publications - Rusana Bark
Department of Clinical Sciences Intervention and Technology, Division of ENT Diseases Karolinska Institutet Stockholm Sweden
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Elsevier in JTCVS Open
Outcome and safety of tracheal and cricotracheal resection in patients with severe comorbidity at a tertiary referral airway center
- 29 October 2026
- Published by Elsevier in JTCVS Open
Open AccessOutcome and safety of tracheal and cricotracheal resection in patients with severe comorbidity at a tertiary referral airway center
- Open Access
- 6 March 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (3) , e70510
Distribution of Sentinel Nodes in Non‐Parotid Salivary Gland Tumors—A Feasibility Study
Background: Salivary gland carcinomas are rare and heterogeneous malignancies, more common in the parotid gland but also in submandibular and minor salivary glands. Surgery, often combined with radiotherapy, is the main treatment. Management of the clinically node‐negative (cN0) neck is debated, with some favoring extensive surgery and others active surveillance. The sentinel node (SN) technique may improve nodal staging and personalized surgery but is understudied in non‐parotid tumors. Aims: This study aimed to evaluate whether the technique is applicable to assess SN distribution in these patients. Methods and Results: In this prospective observational feasibility study, 40 patients with cytologically suspected benign or malignant non‐parotid salivary gland tumors were enrolled. Preoperatively, patients received an ultrasound‐guided intratumoral injection of Tc‐99m‐labeled tracer, followed by SPECT–CT imaging for SN localization. Intraoperatively, SNs were detected using a gamma probe, and sentinel lymph node biopsy (SLNB) was performed when indicated. SNs were detected in 33 of 39 (85%) patients. Bilateral distribution of SNs was seen in two of 12 patients with minor salivary gland tumors but in none with submandibular tumors ( n = 27). One patient was excluded due to a non‐salivary gland diagnosis. SLNB was performed in 16 patients with cytology indicating aggressive malignancies in which micrometastases were detected in three patients with submandibular gland tumors and in two patients with minor salivary gland tumors. Conclusion: SN mapping was feasible in patients with non‐parotid salivary gland tumors, with a high detection rate using SPECT–CT. SN distribution was primarily ipsilateral but bilateral in two patients with minor salivary gland tumors. Identification of SN micrometastases highlights the potential of SLNB to improve staging accuracy. Our findings support further investigation of the SN technique as a diagnostic tool in the management of cN0 neck in this rare tumor group.
- 6 March 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (3) , e70510
Open AccessDistribution of Sentinel Nodes in Non‐Parotid Salivary Gland Tumors—A Feasibility Study
Background: Salivary gland carcinomas are rare and heterogeneous malignancies, more common in the parotid gland but also in submandibular and minor salivary glands. Surgery, often combined with radiotherapy, is the main treatment. Management of the clinically node‐negative (cN0) neck is debated, with some favoring extensive surgery and others active surveillance. The sentinel node (SN) technique may improve nodal staging and personalized surgery but is understudied in non‐parotid tumors. Aims: This study aimed to evaluate whether the technique is applicable to assess SN distribution in these patients. Methods and Results: In this prospective observational feasibility study, 40 patients with cytologically suspected benign or malignant non‐parotid salivary gland tumors were enrolled. Preoperatively, patients received an ultrasound‐guided intratumoral injection of Tc‐99m‐labeled tracer, followed by SPECT–CT imaging for SN localization. Intraoperatively, SNs were detected using a gamma probe, and sentinel lymph node biopsy (SLNB) was performed when indicated. SNs were detected in 33 of 39 (85%) patients. Bilateral distribution of SNs was seen in two of 12 patients with minor salivary gland tumors but in none with submandibular tumors ( n = 27). One patient was excluded due to a non‐salivary gland diagnosis. SLNB was performed in 16 patients with cytology indicating aggressive malignancies in which micrometastases were detected in three patients with submandibular gland tumors and in two patients with minor salivary gland tumors. Conclusion: SN mapping was feasible in patients with non‐parotid salivary gland tumors, with a high detection rate using SPECT–CT. SN distribution was primarily ipsilateral but bilateral in two patients with minor salivary gland tumors. Identification of SN micrometastases highlights the potential of SLNB to improve staging accuracy. Our findings support further investigation of the SN technique as a diagnostic tool in the management of cN0 neck in this rare tumor group.
- Open Access
Does primary posterior tracheopexy prevent collapse of the trachea in newborns with oesophageal atresia and tracheomalacia? A study protocol for an international, multicentre randomised controlled trial (PORTRAIT trial)
Introduction Tracheomalacia (TM) often occurs in children with oesophageal atresia (OA), leading to recurrent respiratory symptoms and in severe cases to blue spells or ultimately respiratory arrest. In some patients, a secondary posterior tracheopexy may then be indicated. This secondary surgery, as well as respiratory morbidity, may be prevented by performing a primary posterior tracheopexy (PPT) concurrent with primary OA correction. The aim of this trial is to determine if a PPT can decrease—or prevent—tracheal collapse in newborns with OA and TM. Additionally, the trial aims to determine whether the potential observed effect of PPT on tracheal stability is sustained over time. Methods and analysis This is an international multicentre double-blind randomised controlled trial. Seventy-eight children with OA type C will be randomised 1:1 into the no-PPT group or PPT group. Randomisation will be stratified by centre. The degree and location of TM are assessed during preoperative, intraoperative and two postoperative tracheobronchoscopies. The occurrence of TM will be evaluated during three routine follow-up consultations until the age of 6 months. The primary outcome is the degree of collapse of the tracheal wall during the intraoperative tracheobronchoscopy (after performing the PPT/no-PPT), measured in percentages. The difference in the mean degree of collapse will be compared between the no-PPT and the PPT groups using linear regression, adjusting for centre and the preoperative degree of tracheal collapse at baseline. The adjusted mean difference will be reported as effect size together with its 95% CI. Ethics and dissemination Patients will be included after written parental informed consent. The risks and burden associated with the trial are minimal. The institutional review board of the University Medical Center Utrecht has approved this protocol (METC-number 23-256/A). Results will be shared in a peer-reviewed scientific journal and presented at international conferences. Trial registration number NCT06335862.
Open AccessDoes primary posterior tracheopexy prevent collapse of the trachea in newborns with oesophageal atresia and tracheomalacia? A study protocol for an international, multicentre randomised controlled trial (PORTRAIT trial)
Introduction Tracheomalacia (TM) often occurs in children with oesophageal atresia (OA), leading to recurrent respiratory symptoms and in severe cases to blue spells or ultimately respiratory arrest. In some patients, a secondary posterior tracheopexy may then be indicated. This secondary surgery, as well as respiratory morbidity, may be prevented by performing a primary posterior tracheopexy (PPT) concurrent with primary OA correction. The aim of this trial is to determine if a PPT can decrease—or prevent—tracheal collapse in newborns with OA and TM. Additionally, the trial aims to determine whether the potential observed effect of PPT on tracheal stability is sustained over time. Methods and analysis This is an international multicentre double-blind randomised controlled trial. Seventy-eight children with OA type C will be randomised 1:1 into the no-PPT group or PPT group. Randomisation will be stratified by centre. The degree and location of TM are assessed during preoperative, intraoperative and two postoperative tracheobronchoscopies. The occurrence of TM will be evaluated during three routine follow-up consultations until the age of 6 months. The primary outcome is the degree of collapse of the tracheal wall during the intraoperative tracheobronchoscopy (after performing the PPT/no-PPT), measured in percentages. The difference in the mean degree of collapse will be compared between the no-PPT and the PPT groups using linear regression, adjusting for centre and the preoperative degree of tracheal collapse at baseline. The adjusted mean difference will be reported as effect size together with its 95% CI. Ethics and dissemination Patients will be included after written parental informed consent. The risks and burden associated with the trial are minimal. The institutional review board of the University Medical Center Utrecht has approved this protocol (METC-number 23-256/A). Results will be shared in a peer-reviewed scientific journal and presented at international conferences. Trial registration number NCT06335862.
- Open Access
- 28 October 2023
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 59 (4) , 678-683
Endoscopic Chemocauterization with Trichloroacetic Acid for Congenital or Recurrent Tracheoesophageal Fistula in Children with Esophageal Atresia: Experience from a Tertiary Center
- 28 October 2023
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 59 (4) , 678-683
Open AccessEndoscopic Chemocauterization with Trichloroacetic Acid for Congenital or Recurrent Tracheoesophageal Fistula in Children with Esophageal Atresia: Experience from a Tertiary Center
- Open Access
- 30 September 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (19) , 19667-19672
Distribution of sentinel nodes from parotid tumors–A feasibility study
Background: Optimum management of the N0 neck is unresolved in parotid salivary gland cancer. Sentinel node biopsy (SNB) can reliably detect microscopic lymph node metastasis and its´ clinical use is increasing for head and neck tumors. The object of this study was to establish whether the technique is applicable to detect distribution of sentinel nodes for parotid tumors.Materials and Methods: Prosepective observational study in 30 patients with benign or low‐grade T1‐T2N0 malignant tumors in the parotid gland planned for surgical treatment. Distribution of SN was detected with a preoperative ultrasound‐guided peritumoral injection with a technetium‐99 (Tc‐99 m) laballed tracer followed by a SPECT–CT and intraoperative measurement in the neck and parotidal tissue. In patients with cytologically suspected malignant tumor or highly unclerar cytology, SNB was also performed.Results: Sentinel nodes (SNs) were detected in 26/30 cases. Out of these, 7 presented with only one SN, whereas multiple sentinel nodes where detected in 19 cases. No SNs were found in neck level 1. SN was detected in level 5 independent of tumor location within the parotid gland. An intraparotidal distribution of SNs was more frequent in larger tumors.Conclusions: The use of SN‐technique in the planning of surgical treatment of parotid tumors seems feasible. It may be of clinical value for patients with parotid cancer to enable a more accurate staging and to detect occult metastasis in the SNs within the parotid as well as in the neck, enabaling the possibility to surgically remove all positive SNs at primary surgery and with reduced surgical morbidity.
- 30 September 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (19) , 19667-19672
Open AccessDistribution of sentinel nodes from parotid tumors–A feasibility study
Background: Optimum management of the N0 neck is unresolved in parotid salivary gland cancer. Sentinel node biopsy (SNB) can reliably detect microscopic lymph node metastasis and its´ clinical use is increasing for head and neck tumors. The object of this study was to establish whether the technique is applicable to detect distribution of sentinel nodes for parotid tumors.Materials and Methods: Prosepective observational study in 30 patients with benign or low‐grade T1‐T2N0 malignant tumors in the parotid gland planned for surgical treatment. Distribution of SN was detected with a preoperative ultrasound‐guided peritumoral injection with a technetium‐99 (Tc‐99 m) laballed tracer followed by a SPECT–CT and intraoperative measurement in the neck and parotidal tissue. In patients with cytologically suspected malignant tumor or highly unclerar cytology, SNB was also performed.Results: Sentinel nodes (SNs) were detected in 26/30 cases. Out of these, 7 presented with only one SN, whereas multiple sentinel nodes where detected in 19 cases. No SNs were found in neck level 1. SN was detected in level 5 independent of tumor location within the parotid gland. An intraparotidal distribution of SNs was more frequent in larger tumors.Conclusions: The use of SN‐technique in the planning of surgical treatment of parotid tumors seems feasible. It may be of clinical value for patients with parotid cancer to enable a more accurate staging and to detect occult metastasis in the SNs within the parotid as well as in the neck, enabaling the possibility to surgically remove all positive SNs at primary surgery and with reduced surgical morbidity.
- Open Access
- 17 June 2023
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 171, 111632
Supraglottoplasty for severe laryngomalacia can be effective and safe also in children with high-risk comorbidities – Experience from a tertiary center
- 17 June 2023
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 171, 111632
Open AccessSupraglottoplasty for severe laryngomalacia can be effective and safe also in children with high-risk comorbidities – Experience from a tertiary center